<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03513835</url>
  </required_header>
  <id_info>
    <org_study_id>H-17032512</org_study_id>
    <nct_id>NCT03513835</nct_id>
  </id_info>
  <brief_title>Diagnostic Screening Tests and Potential Biomarkers in Mitochondrial Myopathies</brief_title>
  <official_title>Diagnostic Screening Tests and Potential Biomarkers in Mitochondrial Myopathies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to develop simple diagnostic screeningtests and investigate
      potential biomarkers for identifying patients with abnormalities of mitochondrial function,
      which also can be used as outcome measures in future clinical trials. The study will
      investigate two submaximal tests: a submaximal handgrip test and a walking test. Furthermore
      investigators will investigate Acyl-carnitine profiles and GDF-15 levels in patients with
      mitochondrial myopathy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <primary_outcome>
    <measure>Serum lactate / pyruvate ratio</measure>
    <time_frame>1 hour</time_frame>
    <description>Changes between: before, during and after submaximal exercise</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum Acyl-carnitine levels</measure>
    <time_frame>1 hour</time_frame>
    <description>Changes between: before and after exercise, fasted and fed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum GDF-15</measure>
    <time_frame>1 hour</time_frame>
    <description>Changes between: before and after exercise, fasted and fed.</description>
  </primary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Mitochondrial Myopathies</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Diagnostic screenings tests</intervention_name>
    <description>Handgrip test, 12-minute walk test and 6-minute walk test. Biomarkers: acyl-carnitine profile and GDF-15.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Genetically verified primary Mitochondrial disorder with myopathy.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 18-75

          -  verified mitochondrial myopathy

          -  or healthy control

          -  or disease control (another neuromuscular disease)

        Exclusion Criteria:

          -  Patient has any prior or current medical conditions that, in the judgment of the
             Investigator, would prevent the patient from safely participating in and/or completing
             all study requirements.

          -  Patient has symptoms of mitochondrial myopathy due to known secondary mitochondrial
             dysfunction

          -  Patient does not have the cognitive capacity to understand/comprehend and complete all
             study assessments.

          -  Pregnancy or breastfeeding.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nicoline Løkken, MD</last_name>
    <phone>+45 3545 8748</phone>
    <email>Nicoline.Loekken@regionh.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Copenhagen Neuromuscular Center, Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicoline Løkken</last_name>
      <phone>+45 3545 8748</phone>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 15, 2018</study_first_submitted>
  <study_first_submitted_qc>April 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 2, 2018</study_first_posted>
  <last_update_submitted>April 19, 2018</last_update_submitted>
  <last_update_submitted_qc>April 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Nicoline Løkken</investigator_full_name>
    <investigator_title>MD, PhD-student</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscular Diseases</mesh_term>
    <mesh_term>Mitochondrial Myopathies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

